The past three decades have borne witness to many advances in the understanding of the
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus …

Epidemiological trends during the past decade suggest that although incidence of
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from …

Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the
nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these …

PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …

Background Patients with locoregionally advanced nasopharyngeal carcinoma have a high
risk of disease relapse, despite a high proportion of patients attaining complete clinical …

Background The value of adding cisplatin, fluorouracil, and docetaxel (TPF) induction
chemotherapy to concurrent chemoradiotherapy in locoregionally advanced …

Purpose: We aimed to evaluate the value of deep learning on positron emission tomography
with computed tomography (PET/CT)–based radiomics for individual induction …

Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China,
and patient prognosis has improved significantly over the past three decades because of …

Background A previous individual patient data meta-analysis by the Meta-Analysis of
Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group to assess the …

Nasopharyngeal carcinoma is characterised by distinct geographical distribution and is
particularly prevalent in east and southeast Asia. Epidemiological trends in the past decade …